Agenus Inc AGEN:NASDAQ

Last Price$1.84NASDAQ Closing Price as of 4:00PM ET 6/28/22

Today's Change-0.04(2.13%)
Bid (Size)$1.84 (10)
Ask (Size)$1.96 (53)
Day Low / High$1.80 - 1.91
Volume4.2 M
  • Latest Stories
  • Commentary and Analysis
Agenus Enters Clinical Collaborations for Tumor Treatments; Shares Rise
10:55AM ET 5/31/2022 MT Newswires

Agenus (AGEN) said Tuesday it has entered into three clinical collaborations with Targovax, Oxford BioTherapeutics and Immunogenesis to develop treatments...

Agenus Says Gilead Hits Clinical Milestone for Melanoma Drug Candidate, Triggering $5 Million Payment
10:20AM ET 4/05/2022 MT Newswires

Agenus (AGEN) said Tuesday its collaboration partner Gilead Sciences (GILD) has achieved a clinical milestone for melanoma drug candidate AGEN2373,...

Agenus to Supply Adjuvant Under Cancer Vaccine Clinical Collaboration With Targovax ASA
8:16AM ET 3/07/2022 MT Newswires

Agenus (AGEN) has entered a clinical collaboration and supply agreement to combine its QS-21 Stimulon adjuvant with clinical stage biotechnology company...

--B. Riley Lowers Agenus' Price Target to $8 from $11, Keeps Buy Rating
9:49AM ET 3/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--HC Wainwright Adjusts Agenus' Price Target to $14 from $12, Reiterates Buy Rating
11:07AM ET 3/02/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Agenus Posts Wider Q4 Loss, Lower Revenue; Shares Fall
9:12AM ET 3/01/2022 MT Newswires

Agenus (AGEN) reported Tuesday its Q4 loss widened to $0.26 per share from $0.20 per share a year ago. Four analysts polled by Capital IQ expected a loss...

--HC Wainwright Starts Agenus at Buy With $12 Price Target
7:04AM ET 12/16/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Agenus Swings to Q3 Earnings as Revenue Increases; Shares Rise Pre-Bell
8:49AM ET 11/09/2021 MT Newswires

Agenus (AGEN) on Tuesday swung to Q3 earnings of $0.72 per share from a loss of $0.28 per share a year earlier. Three analysts polled by Capital IQ...

Update: Agenus to Withdraw Biologics License Application for Cervical Cancer Drug Candidate; Shares Slump
2:07PM ET 10/22/2021 MT Newswires

(Updates with share price in second paragraph) Agenus (AGEN) said Friday that it is withdrawing its biologics license application for cervical cancer drug...

Agenus to Withdraw Biologics License Application for Cervical Cancer Drug Candidate; Shares Fall Pre-Bell
9:22AM ET 10/22/2021 MT Newswires

Agenus (AGEN) said Friday it is withdrawing its biologics license application for cervical cancer drug candidate balstilimab at the recommendation of the...